An immune system kinase promotes tumor inflammation and progression, according to a study published in Nature Communications.
An epigenetic inhibitor increased immune system activity in patients with ovarian cancer.
An enzymatic modifier of messenger RNA has different functions depending on its location, according to a recent study.
A deep learning model has discovered genetic variations in cancer that are undetectable in traditional genome sequencing.
Recent studies have pointed to an expanded role for non-coding RNA, according to a Northwestern Medicine review.
Investigators have discovered a new method to determine whether individual genetic variants in the epilepsy-associated gene SZT2 cause the neurodevelopmental disorder, according to a Northwestern Medicine study.
A newly discovered inhibitor of a common cancer-causing protein operates selectively, reducing expression of genes that fuel rampant cell proliferation, and altering the epigenome, according to a recent study.
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.
Northwestern Medicine scientists identified critical regulatory processes that govern differentiation in embryonic stem cells.